GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Novo Nordisk A/S NOVO B.CO · DKK

Health Care · Nasdaq Copenhagen · 🇩🇰 Denmark

Compare

272.80

+1.24%

Close of 9 Nov 2026, in DKK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Novo Nordisk A/S — daily NOVO B

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Novo Nordisk A/S on TradingView ↗
Market value
DKK 1.21trn
Last close × shares
Volume
4.3m
Shares, 9 Nov 2026
Price to earnings
12.4
Dividend yield
4.10%

About Novo Nordisk A/S

Its shares trade on Nasdaq Copenhagen under the ticker NOVO B.CO. It has been listed since 17 May 1974. In the fiscal year to 31 December 2025, it reported revenue of DKK 309.06bn and net income of DKK 102.43bn. At that date it held total assets of DKK 542.90bn and shareholders' equity of DKK 194.05bn.

Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. The firm is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The firm's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The firm's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The firm also offers Saxenda product to treat obesity. The company offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.

Figures and description from our data supplier, not checked against the company's own report.

More about Novo Nordisk A/S →

Latest on Novo Nordisk A/S

Our reporting

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Novo Nordisk A/S's ticker?

Novo Nordisk A/S trades as NOVO B.CO on Nasdaq Copenhagen, under ISIN DK0062498333.

What was Novo Nordisk A/S's last closing price?

272.80 on 9 Nov 2026. The figure is in DKK and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.